PSUSA/00010801/202507 - periodic safety update report single assessment

poliovirus type 1 / poliovirus type 2 / poliovirus type 3 vaccine (oral, live, attenuated), poliovirus type 1 / poliovirus type 3 vaccine (oral, live, attenuated),poliovirus type 1 (oral, live, attenuated) vaccine, poliovirus type 2 (oral, live, attenuated) vaccine, poliovirus type 3 (oral, live, attenuated) vaccine

About

Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.

Key facts

• Active substance(s) in scope of the PSUSA procedure:
  poliovirus type 1 / poliovirus type 2 / poliovirus type 3 vaccine (oral, live, attenuated), poliovirus type 1 / poliovirus type 3 vaccine (oral, live, attenuated),poliovirus type 1 (oral, live, attenuated) vaccine, poliovirus type 2 (oral, live, attenuated) vaccine, poliovirus type 3 (oral, live, attenuated) vaccine
• Procedure number:
  PSUSA/00010801/202507
• Regulatory outcome:
  Maintenance

Documents

Poliovirus : List of nationally authorised medicinal products - PSUSA/00010801/202507

Reference Number: EMADOC-1700519818-2992191